- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
175 results for yuii
LXRX Stock Alert: Why Lexicon Pharmaceuticals Is Up 100%+ Today
Lexicon Pharmaceuticals (LXRX) stock is on the rise Thursday after announcing an update from the FDA for its drug sotagliflozin.
ACST Stock Alert: 13 Things for Acasti Pharma Investors to Know as Shares Rocket Monday
Acasti Pharma (ACST) stock is on the rise Monday with heavy trading of its shares despite a lack of news concerning the company.
Check-Cap Ltd.: 6 Things for Potential CHEK Stock Investors to Know About the Biotech Company
Check-Cap Ltd. (CHEK) stock is on the rise Monday despite a lack of news from the maker of the C-Scan colorectal cancer screening device.
VXRT Stock Alert: 2 Things for Vaxart Investors to Know as Shares Pop Today
Vaxart (VXRT) stock is heading higher Tuesday and there are a couple of things investors will want to keep in mind about the biotech company.
PTE Stock Alert: 7 Things for Investors to Know About PolarityTE as Shares Soar
PolarityTE (PTE) stock is soaring higher on Friday as investors prepare for its participation in an upcoming event on Monday.
LXRX Stock: Why Lexicon Pharmaceuticals Is Soaring Tuesday
Lexicon Pharmaceuticals (LXRX) stock is soaring higher on Tuesday after getting an upgrade from Citi analyst Yigal Nochomovitz.
OBLN Stock: 11 Things to Know About Weight Loss Balloon Play Obalon Therapeutics
Obalon Therapeutics (OBLN) stock is skyrocketing higher Monday on heavy trading despite a lack of news from the medical device company.
Sutro Biopharma: 7 Things for STRO Stock Investors to Know About the Biotech Company
Sutro Biopharma (STRO) is on the rise Friday with heavy trading of STRO stock despite the company not announcing anything new today.
Iterum Therapeutics News: Why ITRM Stock Is Rocketing Higher Today
Iterum Therapeutics (ITRM) is in the news Thursday following news of massive stakes in the company pushing ITRM stock higher.
Catabasis Pharmaceuticals: 9 Things for Potential CATB Stock Investors to Know
Catabasis Pharmaceuticals (CATB) stock is taking off on Wednesday despite a lack of news from the biopharmaceutical company.
Epilepsy Drug News: Why Addex Therapeutics (ADXN) Stock Is Soaring Today
Addex Therapeutics (ADXN) stock is soaring higher on Thursday after announcing news concerning a clinical trial for its epilepsy drug.
Jaguar Health: 10 Things for JAGX Stock Investors to Know About the Pharmaceutical Company
Jaguar Health (JAGX) is on the move Tuesday as shares of JAGX stock continue to rise and InvestorPlace has what investors need to know.
OBSV Stock: 7 Things for ObsEva Investors to Know Before Investing in the Penny Stock
ObsEva (OBSV) stock is soaring higher on Friday as shares see heavy trading despite there not being any noteworthy news today.
Milestone Pharmaceuticals News: Why MIST Stock Is Skyrocketing 114% Today
Milestone Pharmaceuticals (MIST) news for Thursday includes new guidelines for a clinical study pushing MIST stock higher.
ATOS Stock: 8 Things for Investors to Know About Atossa Therapeutics as It Soars Thursday
Atossa Therapeutics (ATOS) stock is on the rise with heavy trading Thursday after announcing some positive breast cancer news.
AVXL Stock: 6 Things for Investors to Know About Anavex Life Sciences
Anavex Life Sciences (AVXL) stock is soaring higher Thursday on heavy trading despite a lack of news concerning the company.
XTNT Stock: 7 Things to Know About Xtant Medical as Shares Rocket 150%
Xtant Medical (XTNT) stock is surging higher Friday and InvestorPlace has everything potential investors need to know about the company.
AI Stock: Why C3 AI Shares Are Surging Today
C3 AI (AI) stock is on the rise Tuesday after announcing a partnership with Shell (RDS), Baker Hughes (BKR), and Microsoft (MSFT).
Arvinas News Alert: Why ARVN Stock Is Skyrocketing Today
Arvinas (ARVN) news for Monday includes positive interim results from clinical trials sending ARVN stock soaring to new highs.
Xenetic Biosciences News: Why XBIO Stock Is Going Ballistic Today
Xenetic Biosciences (XBIO) news for Wednesday includes positive news from a Phase 3 clinical trial boosting XBIO stock higher.
Lexicon Pharmaceuticals News: Why LXRX Stock Is Soaring 43% Today
Lexicon Pharmaceuticals (LXRX) news for Tuesday includes LXRX stock soaring higher on results from a Phase 3 clinical trial.
Aim ImmunoTech News: Why AIM Stock Is Shooting 22% Higher Today
Aim ImmunoTech (AIM) is in the news Tuesday after positive results from an Early Access Program (EAP) sent AIM stock soaring higher.
Interpace Biosciences News: Why IDXG Stock Is Soaring 48% Today
Interpace Biosciences (IDXG) news for Wednesday includes a positive audit committee result giving IDXG stock a much-needed boost.
2 – 8 of 175 results
